the endoplasmic reticulum and the CFTR protein is degraded. Restoration of CFTR trafficking in vitro restores cAMP-mediated chloride transport at the cell surface. The hypothesis of
TRAFFICKING DEFECTS IN CFTR CAN
this discussion is that the short chain fatty acids, butyrate and 4-phenylbutyrate, up-regulate mature CFTR at the plasma
BE CORRECTED
membrane. Evidence that these compounds regulate CFTR Cystic fibrosis transmembrane conductance regulator production and maturation in part through effects on molecular (CFTR) biosynthesis is a balance between normal prochaperones in CF cells in culture is discussed. The oral drug, 4-phenylbutyrate, was tested in a Phase I clinical trial in CF cessing and proteolysis (Fig. 1A) . Membrane glycoprosubjects and further trials are underway. Other new therapeutic teins typically assemble in the endoplasmic reticulum approaches directed at different classes of mutations in CFTR where they are core-glycosylated, then move to the Golgi are also discussed. Chemical and pharmacologic agents that apparatus to complete glycosylation, and then arrive at regulate endogenous gene expression at different steps in the the plasma membrane, via vesicles that bud off from biosynthetic processing pathway of a membrane glycoprotein will be needed to comprehensively treat a complex inherited the Golgi. In vitro studies in heterologous cell culture disorder like cystic fibrosis.
systems suggest that at best, only 25% of newly synthesized wild-type CFTR escapes the endoplasmic reticulum to be glycosylated in the Golgi and inserted onto the Despite 10 years of intensive investigation of the geplasma membrane attaining a final mobility of about 180 netics, pathophysiology, and clinical phenotypes of cystic kDa on SDS-PAGE [8] [9] [10] . The other 75% of apparently fibrosis (CF), the disease remains one of the most comnormal protein is ubiquitinated and degraded [11] . mon lethal inherited autosomal recessive disorders in ⌬F508 is even less successful than wild type CFTR. the Caucasian population worldwide. The gene encodes ⌬F508 CFTR fails to progress to the Golgi apparatus and the cystic fibrosis transmembrane conductance regulator the cell surface (Fig. 1C) , and runs as a core-glycosylated (CFTR) protein, a 1480 amino acid, glycosylated, memprotein of approximately 150 kD on an SDS-PAGE gel. brane glycoprotein that functions as a cAMP-regulated Failure to pass through the Golgi can be recognized by chloride channel in exocrine glands or secretory epithelia failure to become fully glycosylated and attain a mobility [1]. Seventy percent of patients carry one or two copies of of 170 to 180 kD on an SDS-PAGE gel (Band C, Fig. the ⌬F508 mutation, and over 800 additional mutations 1A). The deletion of the phenylalanine at position 508 account for the remaining disease-causing alleles. The is hypothesized to result in misfolding of the nascent ⌬F508 allele is a trafficking mutation, meaning that the chain as it emerges from the ribosome, where it is recogmutant protein is blocked from maturation in the endonized by the molecular chaperones that target it for early plasmic reticulum and is targeted for premature proteolproteolysis. There is much evidence for misfolding of ysis [2] . Although chloride channel conductance is af-CFTR: a reduced stability of ⌬F508 at the cell membrane fected to some degree [3] [4] [5] [6] , if the ⌬F508 protein is [12] , slightly altered circular dichroism spectra of a pepredirected to the cell surface, cAMP-mediated chloride tide containing this site [13] , restoration of processing by incubation of cells at temperatures between 25 and protein trafficking is seen for mutations in the alpha 1 -up-regulate CFTR expression. However, it is not yet clear that up-regulation of ⌬F508 mRNA expression antitrypsin gene, aquaporin-2 in nephrogenic diabetes insipidus [14] , Tay-Sachs disease, familial hypercholeswould be sufficient to overwhelm the cellular stress mechanisms leading to premature destruction, or whether adterolemia, and for accumulation of insoluble protein aggregates in Alzheimer's and prion-associated disorders.
ditional genes in the trafficking pathway must be modulated. Low molecular weight fatty acids, such as butyrate It was initially hypothesized that by blocking ER-associated proteolytic degradation, a greater amount of maand phenylbutyrate, restore ⌬F508 to the cell surface at 37ЊC in culture [19] . Treatment of CF cell cultures ture ⌬F508-CFTR would be produced. However, inhibition of CFTR proteolysis by lactacystin or ALLN does expressing endogenous levels of ⌬F508 with sodium butyrate or sodium 4-phenylbutyrate at nontoxic concennot force CFTR through the normal pathway [11] . Thus, trations increases total CFTR protein and normal CFTR therapeutic interventions designed to restore normal processing and leads to cAMP-mediated chloride contrafficking must be targeted proximal to ubiquitination duction at the cell surface [20] . Butyrate-mediated effects and proteolysis in the endoplasmic reticulum. Detailed on CFTR may be at least twofold-an induction of studies of nascent CFTR polypeptide chain interactions CFTR expression and modulation of molecular chaperwith molecular chaperones would be informative.
one expression. Wild-type CFTR "folding" and progression to a prote-TEMPERATURE-SENSITIVE ase-resistant state is assisted by endoplasmic reticulum CFTR TRAFFICKING (ER)-associated chaperone proteins. Heat shock protein Growth of ⌬F508 CFTR-expressing cells at reduced 70 (Hsp70) [21] and calnexin [22] , but not BiP and Grp94 temperature (25 to 30ЊC) dramatically corrects the traf-
[2] appear to associate with CFTR transiently. Prolongaficking defect and restores cAMP-mediated chloride tion of the complex of Hsp70 and ⌬F508 CFTR has been transport at the plasma membrane [12] This effect can observed, suggesting that Hsp70 may recognize CFTR be mimicked at 37ЊC by chemical "chaperones" such as for early removal. Hsc70, a member of the Hsp70 family, glycerol, dimethylsulfoxide (DMSO), trimethylamine-Nis constitutively expressed, and has also been implicated oxide (TMAO), and deuterated water [15] . Extremely as a signal for removal to the proteolytic pathway [23] . high concentrations are required, and thus, direct in vivo Hdj-2/Hsc70 complexes associate with wild-type and application is impractical. High throughput screening ⌬F508 CFTR [24] . Preliminary data implicate a phenyland combinatorial chemistry approaches may accelerate butyrate-mediated specific reduction in Hsc70 to explain the identification of a clinically applicable compound.
the shift of mutant CFTR onto the trafficking pathway Studies of organ-specific adaptations to stress may also [8] . Because ⌬F508 retains some chloride channel activity [4, 5], modulation of these chaperone associations provide clues to alternative chemical chaperones. The or additions of a chemical chaperone are reasonable kidney has adapted local environments to protect itself therapeutic avenues. against hyperosmotic stress. By accumulation of "celluIn a randomized, double-blind, placebo-controlled lar osmolytes," urea-mediated protein denaturation is trial in CF patients homozygous for ⌬F508, one week of avoided. TMAO is synthesized by the renal medulla phenylbutyrate, at 20 g/day, was associated with a modest to protect the intracellular environment against urea.
induction of chloride transport based on nasal potential Carbohydrates or myoinositol, free amino acids such as difference measurements [25] . Importantly, no safety isglycine or alanine, and methylamines such as betaine, sues arose in the CF trial, suggesting that a moderate, are either transported in or synthesized by other tissues but selective, reduction in Hsc70 was not associated with in hyperosmotic stress [15] . It might be possible to adapt widespread disruption of the quality control mechanism these principles locally within the lung, liver, or intestine.
for folding or degrading proteins. 4-Phenylbutyrate (Buphenyl) is a newly approved drug for the rare inherited BUTYRATE-MEDIATED CORRECTION OF urea cycle disorders, where it functions to provide an CFTR PROCESSING alternative vehicle for waste nitrogen excretion by conjuGene expression (fetal hemoglobin is one example) gation with glutamine. 4-Phenylbutyrate is under study in can be modulated by small chain fatty acids such as the hemoglobinopathies [26, 27] , adrenoleukodystrophy butyric acid and its derivatives. The effect can be repro- [28] , and in cancer trials [29] . Dose escalation and pharduced by inhibitors of histone deacetylase [16] . Genes macokinetic studies are continuing in adults with CF. active during fetal development are usually silenced in There may be other pharmaceuticals capable of regupostnatal life. Inhibition of histone deacetylase delating the molecular chaperones. Deoxyspergualin (DSG) represses fetal hemoglobin and many other genes. Given is a stable synthetic analog of the natural product sperguthat CFTR is also more abundant in fetal than adult alin, and is known to compete effectively for binding with Hsp70 and Hsp90. DSG has potent immunosuppressive tissue [17, 18] , it is not surprising that the butyrates can activity mediated in part through interactions with Hsc70 mutation. G551D is a Class III mutation that is syntheand Hsp90. One research group has studied DSG and sized, resides in the plasma membrane, but is not actireported appearance of functional cAMP-stimulated vated with isoproterenol (Fig. 1D) . The ability of gen-CFTR chloride channel activity at the cell surface in istein to activate G551D in the intestine of the G551D both immortalized human CF airway and biliary epithe-CF mouse has also been observed [40] . lial cells [30] .
NEW APPROACHES TO CLASS I DEFECTS CFTR CHLORIDE CHANNEL ACTIVATORS
IN CFTR The previous discussion has been confined to modulaPharmacologic correction of CFTR defects must take tors of trafficking; however, the ⌬F508 CFTR is still less under consideration the full range of observed abnormalactive as a chloride channel than normal CFTR. Both ities. Beginning with the Class I defects, it is clear that a trafficking and chloride channel properties appear, at variety of approaches will be required. Class I mutations least in vitro, to be favorably altered by CPX (8-cyclogenerate premature stop codons that result in truncated pentyl-1,3-dipropylxanthine) [31, 32] , an adenosine remRNA transcripts that are inherently unstable and fail ceptor antagonist that directly binds to ⌬F508 CFTR to be translated into proteins (Fig. 1B) . The efficiency in a region that structurally resembles the adenosine of translation termination tends to vary as a function of receptor. A Phase I dose escalation and safety trial was the surrounding amino acid, that is, context-sensitivity. recently completed in CF, and a Phase II trial is in progCertain aminoglycosides, such as G418 and gentamicin, ress. Other analogs are undergoing laboratory assesssuppress premature chain termination and restore readment and look very promising [33] .
through (Fig. 1D ). G551D is a common ence response to isoproterenol [38] .
Class III mutation that does not conduct chloride in Genistein and other flavonoid compounds effectively response to elevated cAMP, but is trafficked to the activate chloride conduction through the ⌬F508 CFTR plasma membrane. Other Class III mutations can inter-[39], although they do not appear to favorably restore fere with nucleotide binding and hydrolysis, and disrupt trafficking. One group has demonstrated that pretreat-CFTR function to a variable degree. These mutants susment of CF cells with 4-phenylbutyrate or low temperatain a reduced response to adenosine 5Ј-triphosphate ture to induce ⌬F508 trafficking to the plasma mem-(ATP); examples include S1255P, G551S, G1244E, and brane, allowed genistein to activate chloride transport G1349D. It may be possible to find molecules that alter (abstract; Fischer et al, Pediatr Pulmon S17:239, 1998).
the interaction of the CFTR domains with ATP and Results from a pilot clinical trial of topical genistein in restore activity to these mutants. CF nasal epithelia alone or in combination with isoproterenol demonstrated a modest hyperpolarization in the CLASS IV CONDUCTION MUTATIONS ARE nasal potential difference response to low chloride in ASSOCIATED WITH A MILD PHENOTYPE normal volunteers, but not in CF patients homozygous Class IV mutants such as R117H, G314E, R334 W, and for ⌬F508. Restoration of ⌬F508 CFTR trafficking will R347P are associated with normal trafficking, protein be necessary for the flavonoids to be effective (abstract; kinase A (PKA)-dependent response to phosphorylaGondor et al, Pediatr Pulmon S17:253, 1998). On the tion, and ATP binding. Defects instead lie in chloride other hand, genistein alone induced a small chloride response in CF patients carrying one copy of the G551D conductance or channel gating (Fig. 1E) . The mutations tend to occur within the regions of CFTR that form the SUMMARY chloride pore. R347P affects the rate of chloride flow, Chemical and pharmacologic mediators of protein whereas R117H and P574H reduce the channel open trafficking are needed in CF and other diseases caused time. The latter mutation is sometimes placed in Class by trafficking mutations. Drugs that regulate endogenous II because of a reduced efficiency of processing. The gene expression may also be useful in the induction of milder clinical phenotypes observed in patients with a alternative enzymatic pathways in diseases such as CF, Class IV mutation suggest that treatments aimed at prothe hemoglobinopathies, adrenoleukodystrophy, and moting CFTR trafficking and activating or increasing cancer. CF is one example where multiple approaches will be needed due to the spectrum of abnormalities chloride conductance would tend to support a milder observed. Certainly, genotyping will become clinically course.
indicated in all the inherited disorders and thus may One drug that may be capable of stimulating Class IV specifically direct therapeutic intervention. CFTR chloride conduction is an approved phosphodiesterase inhibitor that sustains elevated cAMP. Milrinone ACKNOWLEDGMENTS (together with forskolin to initiate elevated cAMP) favorably restores cAMP-mediated chloride secretion to that cause inefficient levels of protein to be produced, 6 . Li C, Ramjeesingh M, Reyes E, Jensen T, Chang X, Rommens are grouped together in Class V (Fig. 1F) . When splicing JM, Bear CE: The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat Genet 3:311-efficiency is reduced, variable levels of normal CFTR 316, 1993 can escape to provide some function as is seen with these patients might confer clinical benefit.
